03/06/2024
4:13 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:15 PM | BridgeBio Pharma (Filer)
| Form 424B5 | |
03/04/2024
6:00 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
6:15 PM | BridgeBio Pharma (Subject)
Kumar Neil (Filed by)
| Form SC 13G/A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
BridgeBio Pharma (Subject)
| Form SC 13G/A | |
01/23/2024
9:16 AM | BridgeBio Pharma (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
|
01/18/2024
3:10 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
6:30 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
4:14 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
4:33 PM | BridgeBio Pharma (Subject)
MCCORMICK FRANK (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
3:15 PM | BridgeBio Pharma (Subject)
Scott Randal W. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
3:20 PM | BridgeBio Pharma (Subject)
Scott Randal W. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
3:15 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
11/17/2023
3:27 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/17/2023
3:27 PM | BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023
3:03 PM | BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
3:00 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
3:00 PM | BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:14 PM | BridgeBio Pharma (Subject)
Scott Randal W. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023
3:12 PM | BridgeBio Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
6:32 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2023
8:52 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
07/19/2023
8:33 PM | BridgeBio Pharma (Issuer)
HALVORSEN OLE ANDREAS (Reporting)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Parent GP LLC (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
8:31 PM | BridgeBio Pharma (Subject)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023
6:23 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
3:17 PM | BridgeBio Pharma (Issuer)
DANIELS RONALD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:18 PM | BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:19 PM | BridgeBio Pharma (Issuer)
Hassan Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:20 PM | BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:21 PM | BridgeBio Pharma (Issuer)
Lo Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:22 PM | BridgeBio Pharma (Issuer)
MOMTAZEE JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:23 PM | BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:24 PM | BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:25 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:14 PM | AGUIAR ERIC (Reporting)
BridgeBio Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:05 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2023
3:46 PM | BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2023
3:48 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/04/2023
4:18 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
05/04/2023
4:20 PM | BridgeBio Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/04/2023
6:46 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
